Hoe Leong Corporation Ltd
SGX:H20
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hoe Leong Corporation Ltd
SGX:H20
|
SG |
|
Tokai Soft Co Ltd
TSE:4430
|
JP |
|
S
|
Samyoung Chemical Co Ltd
KRX:003720
|
KR |
|
S
|
SPIC Industry Finance Holdings Co Ltd
SZSE:000958
|
CN |
|
D
|
Dap Gayrimenkul Gelistirme AS
IST:DAPGM.E
|
TR |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
Balance Sheet
Balance Sheet Decomposition
Hoe Leong Corporation Ltd
Hoe Leong Corporation Ltd
Balance Sheet
Hoe Leong Corporation Ltd
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
3
|
3
|
6
|
3
|
5
|
5
|
6
|
8
|
14
|
11
|
11
|
6
|
3
|
3
|
2
|
3
|
2
|
3
|
3
|
5
|
3
|
3
|
3
|
|
| Cash Equivalents |
2
|
3
|
3
|
6
|
3
|
5
|
5
|
6
|
8
|
14
|
11
|
11
|
6
|
3
|
3
|
2
|
3
|
2
|
3
|
3
|
5
|
3
|
3
|
3
|
|
| Short-Term Investments |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
28
|
24
|
24
|
17
|
23
|
24
|
19
|
18
|
16
|
37
|
41
|
50
|
48
|
61
|
27
|
16
|
19
|
12
|
10
|
15
|
13
|
12
|
15
|
11
|
|
| Accounts Receivables |
27
|
23
|
24
|
16
|
23
|
23
|
19
|
17
|
15
|
36
|
20
|
18
|
19
|
61
|
27
|
16
|
19
|
12
|
10
|
15
|
13
|
12
|
15
|
11
|
|
| Other Receivables |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
20
|
32
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
24
|
24
|
30
|
37
|
36
|
41
|
48
|
36
|
33
|
43
|
61
|
32
|
32
|
28
|
25
|
24
|
23
|
19
|
18
|
18
|
18
|
20
|
19
|
19
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
2
|
1
|
1
|
22
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
54
|
51
|
58
|
61
|
63
|
72
|
73
|
61
|
58
|
94
|
114
|
115
|
86
|
92
|
55
|
42
|
45
|
40
|
31
|
37
|
35
|
36
|
36
|
33
|
|
| PP&E Net |
16
|
17
|
17
|
17
|
19
|
18
|
31
|
54
|
47
|
46
|
43
|
46
|
82
|
79
|
68
|
30
|
27
|
12
|
11
|
9
|
9
|
8
|
8
|
8
|
|
| PP&E Gross |
16
|
17
|
17
|
17
|
19
|
18
|
31
|
54
|
47
|
46
|
43
|
46
|
82
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
4
|
5
|
6
|
7
|
7
|
8
|
9
|
10
|
12
|
11
|
13
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
50
|
42
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
|
| Total Assets |
70
N/A
|
68
-3%
|
75
+10%
|
78
+3%
|
81
+4%
|
90
+11%
|
104
+16%
|
115
+10%
|
131
+14%
|
191
+45%
|
200
+5%
|
174
-13%
|
169
-3%
|
172
+2%
|
123
-28%
|
72
-41%
|
73
+1%
|
53
-28%
|
42
-20%
|
46
+10%
|
45
-3%
|
44
-1%
|
45
+1%
|
42
-7%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
21
|
17
|
21
|
18
|
19
|
7
|
5
|
3
|
5
|
10
|
5
|
6
|
7
|
17
|
20
|
29
|
16
|
14
|
11
|
9
|
8
|
5
|
7
|
5
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
4
|
7
|
7
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
6
|
2
|
4
|
9
|
0
|
13
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
35
|
35
|
50
|
79
|
68
|
11
|
26
|
12
|
10
|
7
|
9
|
9
|
7
|
|
| Other Current Liabilities |
15
|
13
|
14
|
14
|
16
|
28
|
35
|
26
|
23
|
23
|
7
|
16
|
18
|
2
|
4
|
4
|
4
|
4
|
4
|
1
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
36
|
31
|
36
|
32
|
35
|
39
|
49
|
34
|
35
|
49
|
70
|
74
|
99
|
69
|
103
|
100
|
31
|
44
|
26
|
19
|
15
|
15
|
16
|
13
|
|
| Long-Term Debt |
4
|
4
|
1
|
2
|
2
|
1
|
6
|
17
|
18
|
32
|
34
|
25
|
13
|
3
|
0
|
1
|
19
|
2
|
6
|
13
|
6
|
4
|
3
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
1
|
0
|
1
|
1
|
3
|
4
|
5
|
5
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
17
|
12
|
8
|
0
|
34
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
40
N/A
|
36
-10%
|
38
+6%
|
35
-8%
|
37
+5%
|
41
+11%
|
56
+37%
|
55
-2%
|
67
+21%
|
105
+57%
|
121
+16%
|
106
-13%
|
113
+7%
|
106
-7%
|
103
-2%
|
100
-3%
|
49
-51%
|
46
-7%
|
32
-30%
|
32
+0%
|
21
-36%
|
19
-9%
|
19
+3%
|
16
-19%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
6
|
6
|
6
|
38
|
38
|
47
|
47
|
54
|
54
|
54
|
54
|
54
|
64
|
69
|
69
|
69
|
114
|
114
|
114
|
116
|
127
|
129
|
129
|
129
|
|
| Retained Earnings |
26
|
28
|
33
|
6
|
8
|
5
|
4
|
8
|
14
|
35
|
30
|
18
|
5
|
1
|
48
|
97
|
90
|
106
|
104
|
102
|
101
|
101
|
100
|
100
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
4
|
3
|
6
|
4
|
3
|
2
|
2
|
0
|
1
|
1
|
0
|
0
|
1
|
2
|
3
|
3
|
|
| Total Equity |
31
N/A
|
33
+7%
|
37
+14%
|
43
+15%
|
44
+3%
|
49
+11%
|
48
-2%
|
60
+24%
|
65
+8%
|
86
+33%
|
79
-9%
|
68
-14%
|
56
-18%
|
67
+20%
|
20
-70%
|
28
N/A
|
24
N/A
|
7
-70%
|
10
+40%
|
14
+40%
|
24
+72%
|
25
+5%
|
25
0%
|
26
+2%
|
|
| Total Liabilities & Equity |
70
N/A
|
68
-3%
|
75
+10%
|
78
+3%
|
81
+4%
|
90
+11%
|
104
+16%
|
115
+10%
|
131
+14%
|
191
+45%
|
200
+5%
|
174
-13%
|
169
-3%
|
172
+2%
|
123
-28%
|
72
-41%
|
73
+1%
|
53
-28%
|
42
-20%
|
46
+10%
|
45
-3%
|
44
-1%
|
45
+1%
|
42
-7%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
296
|
296
|
296
|
296
|
239
|
334
|
334
|
366
|
366
|
366
|
366
|
366
|
506
|
623
|
623
|
623
|
5 619
|
5 619
|
5 619
|
6 271
|
13 750
|
15 071
|
15 139
|
15 147
|
|